Search Results - "LASOTA, JERZY"

Refine Results
  1. 1

    Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis by Miettinen, Markku, Lasota, Jerzy

    “…Gastrointestinal stromal tumors (GISTs) are specific, generally Kit (CD117)-positive, mesenchymal tumors of the gastrointestinal tract encompassing a majority…”
    Get full text
    Journal Article
  2. 2

    Gastrointestinal stromal tumors: pathology and prognosis at different sites by Miettinen, Markku, Lasota, Jerzy

    Published in Seminars in diagnostic pathology (01-05-2006)
    “…Gastrointestinal (GI) stromal tumors (GISTs) are the most common mesenchymal tumors specific to the GI tract, generally defined as KIT (CD117)-positive tumors…”
    Get more information
    Journal Article
  3. 3

    Histopathology of gastrointestinal stromal tumor by Miettinen, Markku, Lasota, Jerzy

    Published in Journal of surgical oncology (01-12-2011)
    “…Gastrointestinal stromal tumor (GIST), generally driven by oncogenic KIT or PDGFRA mutations, is the most common mesenchymal tumor of the gastrointestinal (GI)…”
    Get full text
    Journal Article
  4. 4

    Gastrointestinal Stromal Tumors by Miettinen, Markku, MD, Lasota, Jerzy, MD

    Published in Gastroenterology clinics of North America (01-06-2013)
    “…Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor of the gastrointestinal tract. Soon after GIST was recognized as a tumor driven…”
    Get full text
    Journal Article
  5. 5

    Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature by Voltaggio, Lysandra, MD, Murray, Rebecca, MD, Lasota, Jerzy, MD, Miettinen, Markku, MD

    Published in Human pathology (01-05-2012)
    “…Summary Schwannoma is a rare gastrointestinal mesenchymal tumor, as the vast majority of gastric mesenchymal tumors are gastrointestinal stromal tumors. In…”
    Get full text
    Journal Article
  6. 6

    Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas by Inaguma, Shingo, Lasota, Jerzy, Wang, Zengfeng, Felisiak-Golabek, Anna, Ikeda, Hiroshi, Miettinen, Markku

    Published in Modern pathology (01-02-2017)
    “…The CD274 (PD-L1)/PDCD1 (PD-1) pathway is crucial for the modulation of immune responses and self-tolerance. Aberrantly expressed CD274 allows tumor cells to…”
    Get full text
    Journal Article
  7. 7

    Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors by Lasota, Jerzy, Kowalik, Artur, Felisiak-Golabek, Anna, Zięba, Sebastian, Waloszczyk, Piotr, Masiuk, Marek, Wejman, Jaroslaw, Szumilo, Justyna, Miettinen, Markku

    Published in Modern pathology (01-07-2019)
    “…Primary malignant melanoma of esophagus is very rare, and its clinicopathologic and genetic features have not been extensively investigated. In this study, 20…”
    Get full text
    Journal Article
  8. 8

    New fusion sarcomas: histopathology and clinical significance of selected entities by Miettinen, Markku, Felisiak-Golabek, Anna, Luiña Contreras, Alejandro, Glod, John, Kaplan, Rosandra N., Killian, Jonathan Keith, Lasota, Jerzy

    Published in Human pathology (01-04-2019)
    “…Many sarcomas contain gene fusions that can be pathogenetic mechanisms and diagnostic markers. In this article we review selected fusion sarcomas and…”
    Get full text
    Journal Article
  9. 9

    Gastrointestinal stromal tumors : definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis by MIETTINEN, Markku, LASOTA, Jerzy

    “…Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal (GI) tract. They are defined here as KIT (CD117, stem…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs) by Lasota, Jerzy, Miettinen, Markku

    Published in Seminars in diagnostic pathology (01-05-2006)
    “…Mutually exclusive KIT and PDGFRA mutations are central events in GIST pathogenesis, and their understanding is becoming increasingly important, because…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review by Miettinen, Markku, Majidi, Mourad, Lasota, Jerzy

    Published in European journal of cancer (1990) (01-09-2002)
    “…Gastrointestinal stromal tumor (GIST) is the designation for the specific c- kit expressing and Kit-signaling driven mesenchymal tumors, many of which have…”
    Get full text
    Journal Article
  15. 15

    Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors by Inaguma, Shingo, Wang, Zengfeng, Lasota, Jerzy P, Miettinen, Markku M

    Published in Oncotarget (23-08-2016)
    “…The neural cell adhesion molecule L1 (CD171) is a multidomain type 1 membrane glycoprotein of the immunoglobulin superfamily important in the nervous system…”
    Get full text
    Journal Article
  16. 16

    Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 cases by Lasota, Jerzy, Felisiak-Golabek, Anna, Wasag, Bartosz, Kowalik, Artur, Zięba, Sebastian, Chłopek, Małgorzata, Wang, Zeng-Feng, Coates, Tiffany, Kopczynski, Janusz, Gozdz, Stanislaw, Sarlomo-Rikala, Maarit, Miettinen, Markku

    Published in Modern pathology (01-03-2016)
    “…Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors usually driven by the mutational activation of receptor tyrosine kinases, KIT, or PDGFRA…”
    Get full text
    Journal Article
  17. 17

    MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases by Kerkar, Sid P, Wang, Zeng-Feng, Lasota, Jerzy, Park, Tristen, Patel, Krishna, Groh, Eric, Rosenberg, Steven A, Miettinen, Markku M

    Published in Journal of immunotherapy (1997) (01-05-2016)
    “…Two cancer testis antigens, the New York esophageal squamous cell carcinoma-1 (NY-ESO-1) and the melanoma-antigen family A (MAGE-A), represent promising…”
    Get full text
    Journal Article
  18. 18

    Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A review by Miettinen, Markku, El-Rifai, Wa'El, H, Leslie, Lasota, Jerzy

    Published in Human pathology (01-05-2002)
    “…This paper reviews data on the prognosis of gastrointestinal stromal tumors (GISTs). These tumors are specific KIT-expressing and KIT-signaling–driven…”
    Get full text
    Journal Article
  19. 19

    Epithelioid variant of gastrointestinal stromal tumor harboring PDGFRA mutation and MLH1 gene alteration: A case report by Kobayashi, Mizuho, Inaguma, Shingo, Raffeld, Mark, Kato, Hiroyuki, Suzuki, Shugo, Wakasugi, Takehiro, Mitsui, Akira, Kuwabara, Yoshiyuki, Lasota, Jerzy, Ikeda, Hiroshi, Miettinen, Markku, Takahashi, Satoru

    Published in Pathology international (01-09-2019)
    “…Gastrointestinal stromal tumors (GISTs) are the most important and common mesenchymal tumors of the gastrointestinal tract, especially in the stomach. GISTs…”
    Get full text
    Journal Article
  20. 20

    Gastrointestinal Stromal Tumors Presenting as Omental Masses―A Clinicopathologic Analysis of 95 Cases by MIETTINEN, Markku, SOBIN, Leslie H, LASOTA, Jerzy

    Published in The American journal of surgical pathology (01-09-2009)
    “…Gastrointestinal stromal tumors (GISTs), generally KIT-positive and KIT/PDGFRA mutation-driven mesenchymal neoplasms, most commonly originate from the stomach…”
    Get full text
    Journal Article